The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dikke G.B.

Russian Peoples’ Friendship University, Ministry of Science and Education

Significance of oral contraception in prevention of recurrent bacterial vaginosis and reduction the risk of pelvic inflammatory diseases

Authors:

Dikke G.B.

More about the authors

Journal: Russian Journal of Human Reproduction. 2017;23(4): 32‑36

Read: 11860 times


To cite this article:

Dikke GB. Significance of oral contraception in prevention of recurrent bacterial vaginosis and reduction the risk of pelvic inflammatory diseases. Russian Journal of Human Reproduction. 2017;23(4):32‑36. (In Russ.)
https://doi.org/10.17116/repro201723432-36

Recommended articles:
Endo­metriosis-associated infe­rtility and the effi­cacy of dienogest. Russian Journal of Human Reproduction. 2025;(5):58-63
Bacterial vagi­nosis: modern views. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):261-268
Lactobacilli and bacterial vagi­nosis. Species typing and analysis of content levels in the microbiome. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(2):43-50
Correction of vagi­nal microbiocenosis in bacterial vagi­nosis. Promising areas. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):44-50

References:

  1. Dikke GB. Polimikrobnyye assotsiatsii v etiologii vospalitel’nykh zabolevaniy polovykh organov u zhenshchin. Akusherstvo i ginekologiya. 2017;6:121-128. (In Russ.).
  2. Radzinskiy VE, Kaygorodova LA, et al. Korrektsiya narusheniy biotsenoza vlagalishcha : marsh na meste ili dvizheniya vpered? Doktor.Ru . 2011;23-29 (In Russ.).
  3. Kira EF. Bacterial’nyi vaginos. M.: MIA. 2012;472. (In Russ.).
  4. Payne SC, Cromer PR, Stanek MK, et al. Evidence of African-Americans women’s frustrations with chronic recurrent bacterial vaginosis. J Am Acad Nurse Pract. 2010;22(2):101-108.
  5. Islam A. Bacterial vaginosis. J Pak Med Assoc. 2009;59(9):601-604.
  6. Minaev NN, Provotorova TV. Otdalennye rezul’taty primeneniya preparata «Neo-Penotran forte» dlya lecheniya pacientok s bacterial’nym vaginosom. Molodoi uchenyi. 2015;6:283-287. (In Russ.).
  7. Prilepskaya VN, Dovlethanova ER, Bairamova GR. Sovremennyi vzglyad na voprosy etiologii, patogeneza i lecheniya bacterial’nogo vaginosa. Gynecologiya. 2010;2:12:44-48. (In Russ.).
  8. Tihomirov AL, Sarsaniya SI. Sovremennye osobennosti bacterial’nogo vaginosa — tak li vse prosto? Medicinskii vestnik. 2010;31(536):12-14 (In Russ.).
  9. Uglova ND. Probiotiki in lechenii bacterial’nogo vaginosa. Lekarstvennyi vestnik. 2013;4: 29-32. (In Russ.).
  10. Chebotar’ IV, Mayanskyj AN, Konchakova ED, et al. Antibiotikoresistentnost’ bioplenochnyh bacterij. Klinicheskaya microbiologiya. Antimicrobnaya himioterapiya. 2012;14:51-58. (In Russ.).
  11. Youngkin EQ, Lester PB. Promoting self-care and secondary prevention in women’s health: a study to test the accuracy of a home self-test system for bacterial vaginosis. Appl Nurs Res. 2010;23(1):2-10.
  12. Savicheva AM, Balan VE, Rogovskaya SI. Bacterial’nyi vaginos: Ot novyh trendov nauki k prakticheskim resheniyam. Medicinskiye aspecty zdorov’ya zhenchsin. 2014;79:4:47-52. In Russ.).
  13. De Seta F, Restaino S, De Santo D, Stabile G, et al. Effects of hormonal contraception on vaginal flora. Contraception. 2012;86: 5:526-529.
  14. Eschenbacha DA, Pattona DL, Meiera A, Thwina SS, et al. Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium. Contraception. 2000;62:3:107-112.
  15. De Seta F, Restaino S, Banco R, Conversano E, et al. Effects of estroprogestins containing natural estrogen on vaginal flora. Gynecol Endocrinol. 2014;30:11:830-835.
  16. Mueck AO, Sitruk-Ware R. Nomegestrol acetate, a novel progestogen for oral contraception. Steroids. 2011;76:6:531-539.
  17. Nappi RE, Serrani M, Jensen JT. Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature. Int J Womens Health. 2014;6:711-718.
  18. Rogovskaya SI. Vul’vovaginal’nyy i tservikal’nyy epiteliy i gormonal’nyye sredstva. Status Praesens. 2014;6(17):41-47. (In Russ.).
  19. Van de Wijgert JH, Verwijs MC, Turner AN, Morrison CS. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission. AIDS .2013;27(13):2141-2153.
  20. Bradshaw CS, Brotman RM. Making inroads into improving treatment of bacterial vaginosis-striving for long-term cure. BMC Infect Dis. 2015;15(1):292.
  21. Vodstrcil LA, Hocking JS, Law M, et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: A systematic review and metaanalysis. PLoS One. 2013;8(9):e73055.
  22. Burkman RT. Oral contraceptives: current status. Clin Obstet Gynecol. 2001;44(1):62-72.
  23. Aral SO, Brunham RC, Cates W, et al. CDC. Pelvic Inflammatory Disease: Guidelines for Prevention and Management. MMWR. 1991April 26;40(RR-5);1-25.
  24. Washington AE, Gove S, Schachter J, Sweet RL. Oral contraceptives, Chlamydia trachomatis infection and pelvic inflammatory disease: a word of caution about protection. JAMA. 1985;253:2246-2250.
  25. Senanayake P, Kramer DG. Contraception and the etiology of pelvic inflammatory disease: new perspectives. Am J Obstet Gynecol. 1980;138(2):852-860.
  26. Wølner-Hanssen P, Eschenbach DA, Paavonen J, et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA. 1990;263(1):54-59.
  27. Kaunitz AM. Oral contraceptive health benefits: perception versus reality. Contraception. 1999;59(Suppl. 1):29S-33S.
  28. Rubin GL, Ory HW, Layde PM. Oral contraceptives and pelvic inflammatory disease. Am J Obstet Gynecol. 1982;144(6):630-635.
  29. Peterson HB, Lee NC. The health effects of oral contraceptives: Misperceptions, controversies, and continuing good news. Clin Obstet Gynecol. 1989;32:339-355.
  30. Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab. 2013;11(1):41-47.
  31. Vodstrcil LA, Hocking JS, Law M, et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: A systematic review and metaanalysis. PLoS One. 2013;8(9):e73055.
  32. Burkman RT. Oral contraceptives: current status. Clin Obstet Gynecol. 2001;44(1):62-72.
  33. Andrist LC, Arias RD, Nucatola D, et al. Women’s and providers’ attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception. 2004;70:359-363.
  34. Romero R, Hassan SS, Gajer P, et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome. 2014;2:4.
  35. Korkhov VV, Tapil’skaia NI. Gestageny v akushersko-ginekologicheskoi praktike: rukovodstvo dlia vrachei. SPb.: SpetsLit. 2005. (In Russ.).
  36. Bol’shoy plyus kontratseptsii. Rezul’taty issledovaniya v g. M. 2014. Elektronnyy resurs. Rezhim dostupa: https://medi.ru/info/12657/ (In Russ.).
  37. Dikke GB, Yerofeyeva LV. Sovremennyye osobennosti natsional’noy kontratseptsii: informirovannost’, primeneniye i effektivnost’. Voprosy ginek. kush.i perinat. 2014;1(5):63-71. (In Russ.).
  38. Moya luchshaya kontratseptsiya! Itogi internet-oprosa. 2014. Elektronnyy resurs. (In Russ.). Rezhim dostupa: http://tikaisievietem.lv/ru Поступила 07.07.2017

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.